1. Phosphatidylserine-targeting antibodies augment the anti-tumorigenic activity of anti-PD-1 therapy by enhancing immune activation and downregulating pro-oncogenic factors induced by T-cell checkpoint inhibition in murine triple-negative breast cancers. Issue 1 (December 2016) Authors: Gray, Michael; Gong, Jian; Hatch, Michaela; Nguyen, Van; Hughes, Christopher; Hutchins, Jeff; Freimark, Bruce Journal: Breast cancer research Issue: Volume 18:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗